Preclinical Evaluation of Brigimadlin (BI 907828) As a Novel MDM2 Inhibitor in Acute Lymphoblastic Leukemia


APTULLAHOĞLU E.

Black Sea Journal of Engineering and Science, vol.8, no.5, pp.1450-1459, 2025 (TRDizin)